Sopharma Properties REIT (XBUL:SFI) Other Financing: €0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:SFI Sopharma Properties REIT XBUL:SFI
68 GF Score
Price €4.20
GF Value €10.44
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sopharma Properties REIT Other Financing?

Sopharma Properties REIT XBUL:SFI 68 Other Financing is €0.00 Mil as of Jun. 2026. GuruFocus rates XBUL:SFI with a GF Score™ of 68/100 and a GF Value™ of €10.44 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Sopharma Properties REIT's Other Financing for the three months ended in Jun. 2026 was €0.00 Mil.

Sopharma Properties REIT's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was €0.00 Mil.

Sopharma Properties REIT Other Financing Historical Data

* Premium members only.

The historical data trend for Sopharma Properties REIT's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma Properties REIT Other Financing Chart

Sopharma Properties REIT Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 -0.09 -0.09 -0.01 0.00

Sopharma Properties REIT Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XBUL:SFI
68GF Score
Sopharma Properties REIT XBUL:SFI
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma Properties REIT Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €0.00 Mil mean?
Sopharma Properties REIT (XBUL:SFI) has a Other Financing of €0.00 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sopharma Properties REIT and its competitors.
Is Sopharma Properties REIT's Other Financing too high?
Sopharma Properties REIT's current Other Financing is €0.00 Mil. Overall, Sopharma Properties REIT has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Properties REIT's Other Financing compare to VICI and WPC?
Sopharma Properties REIT's Other Financing of €0.00 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a REITs company?
A good Other Financing depends on the REITs industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sopharma Properties REIT and its competitors. Sopharma Properties REIT's current Other Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Properties REIT stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Properties REIT (XBUL:SFI) is currently considered Significantly Undervalued. The stock's GF Value™ is €10.44, compared to a current price of €4.20 — trading 59.8% below its estimated fair value. The current Other Financing is €0.00 Mil. Sopharma Properties REIT's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sopharma Properties REIT (XBUL:SFI), the current Other Financing is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma Properties REIT (XBUL:SFI) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma Properties REIT stock appears to be undervalued. The current stock price of €4.20 is trading 59.8% below its estimated GF Value™ of €10.44. GuruFocus considers Sopharma Properties REIT to be Significantly Undervalued.

Key valuation signals for XBUL:SFI:

  • Other Financing: €0.00 Mil
  • GF Value™: €10.44 vs. price of €4.20 (59.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the XBUL:SFI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sopharma Properties REIT Business Description

Industry Real EstateREITs
Address Ul. Lachezar Stanchev 5, sgrada A, et. 20, Sofia, BGR, 1756
Sopharma Properties REIT is a special purpose investment company for securitization of real estate.
68GF Score

Get the complete analysis for XBUL:SFI

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.20
Price
€10.44
GF Value